Healthcare -
Biotechnology - NASDAQ - US
$ 0.47
-0.844 %
$ 27.3 M
Market Cap
-0.28
P/E
BCAB - CASH & EQUIVALENTS
Cash & Equivalents BCAB - BioAtla, Inc.
111 M
LAST VALUE
-32.54%
2 YEAR CAGR
59.31%
5 YEAR CAGR
0.00%
10 YEAR CAGR